MYD88 and diffuse large B-cell lymphoma: MYD88L265P mutation, which involves the adaptor protein MYD88 in the Toll-like receptor (TLR) pathway, is found in approximately 30% of ABC DLBCL, suggesting that abnormal TLR signaling plays a role in the pathogenesis of DLBCL (22).